Helmut Fuchs, Miguel Torres, Lillian Garrett, Derek Spieler, Christine von Toerne, Darina Czamara, José Bessa, Melanie Waldenberger, Florian Giesert, Peter Lichtner, José Luis Gómez-Skarmeta, Melina Claussnitzer, Thomas Meitinger, Juliane Winkelmann, Helmut Laumen, Bertram Müller-Myhsok, Johannes Beckers, Sabine M. Hölter, Martin Klingenspor, Marion Horsch, Hyun-Ok Kate Lee, Martin Hrabé de Angelis, Wolfgang Wurst, Juan J. Tena, Barbara Schormair, Franziska Knauf, Jan Rozman, Valerie Gailus-Durner, Erik Tilch, Ronald Naumann, Fernando Casares, Christian Gieger, Nazanin Karbalai, Stefanie M. Hauck, Maria Kaffe, Fritz Thyssen Foundation, German Academic Exchange Service, Unión Europea. European Cooperation in Science and Technology (COST), Deutsche Forschungsgemeinschaft (Alemania), Helmholtz Zentrum München, Federal Ministry of Education & Research (Alemania), Ludwig-Maximilians-Universität München (Alemania), Ministerio de Ciencia e Innovación (España), Regional Government of Andalusia (España), Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF), Federal Ministry of Education and Research (Germany), German Research Center for Environmental Health, German Research Foundation, Israel Science Foundation, Technical University of Munich, Free State of Bavaria, Munich Center of Health Sciences, Ludwig Maximilians University Munich, Junta de Andalucía, German Center for Diabetes Research, and Helmholtz Association
This article, published in Genome Research, is available under a Creative Commons License (Attribution-NonCommercial 3.0 Unported).-- et al., Genome-wide association studies (GWAS) identified the MEIS1 locus for Restless Legs Syndrome (RLS), but causal single nucleotide polymorphisms (SNPs) and their functional relevance remain unknown. This locus contains a large number of highly conserved noncoding regions (HCNRs) potentially functioning as cis-regulatory modules. We analyzed these HCNRs for allele-dependent enhancer activity in zebrafish and mice and found that the risk allele of the lead SNP rs12469063 reduces enhancer activity in the Meis1 expression domain of the murine embryonic ganglionic eminences (GE). CREB1 binds this enhancer and rs12469063 affects its binding in vitro. In addition, MEIS1 target genes suggest a role in the specification of neuronal progenitors in the GE, and heterozygous Meis1-deficient mice exhibit hyperactivity, resembling the RLS phenotype. Thus, in vivo and in vitro analysis of a common SNP with small effect size showed allele-dependent function in the prospective basal ganglia representing the first neurodevelopmental region implicated in RLS., The project was supported by Fritz-Thyssen-Stiftung, Cologne, Germany (10.09.2.146; 10.12.2.183), KKF-TUM (8766156), DAAD (0811963), and COST (“HOX and TALE homeoproteins in Development and Disease”). B.S. was partially supported by DFG grants (WI 1820/4-1; WI 1820/5-1) and a TUM-Excellence stipend. The KORA study was financed by the Helmholtz Zentrum München, which is funded by the German Federal Ministry of Education and Research (BMBF) and by the State of Bavaria. KORA research was supported within the Munich Center of Health Sciences (MC Health), Ludwig-Maximilians-Universität, as part of LMUinnovativ. J.L.G.-S. and F.C. acknowledge funding of the Spanish and the Andalusian Governments and the Feder program for grants (BFU2010-14839, BFU2009-07044, CSD2007-00008, and Proyectos de Excelencia CVI-3488 and CVI 2658). This work was funded in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD), to the German Mouse Clinic (Infrafrontier: 01KX1012), to the German Center for Neurodegenerative Diseases (DZNE), Germany; by the Initiative and Networking Fund of the Helmholtz Association in the framework of the Helmholtz Alliance for Mental Research in an Ageing Society (HA-215); and the Munich Cluster for Systems Neurology (EXC 1010 SyNergy) and its Collaborative Research Center (CRC) 870/2 “Assembly and Function of Neuronal Circuits.”